Arcadia Biosciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $1,100 | $901 | $1,302 | $1,455 |
Gross Profit | 400 | 192 | 418 | 631 |
EBITDA | -4,377 | -1,326 | 858 | -4,443 |
EBIT | -4,385 | -1,328 | 856 | -4,458 |
Net Income | -4,385 | -1,336 | 856 | -4,458 |
Net Change In Cash | 1,100 | 901 | 1,302 | 1,455 |
Free Cash Flow | -1,099 | -861 | -257 | -2,033 |
Cash | 954 | 259 | 1,120 | 1,376 |
Basic Shares | 1,368 | 1,369 | 1,371 | 1,367 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,858 | $5,045 | $4,454 | $7,418 |
Gross Profit | 1,760 | 2,082 | 2,280 | 1,317 |
EBITDA | -2,299 | -7,499 | -5,731 | -14,749 |
EBIT | -2,331 | -7,612 | -6,018 | -15,228 |
Net Income | -2,339 | -7,038 | -13,981 | -15,376 |
Net Change In Cash | 4,858 | 5,045 | 4,454 | 7,418 |
Free Cash Flow | -4,739 | -9,643 | -15,299 | -14,049 |
Cash | 259 | 4,242 | 6,518 | 20,644 |
Basic Shares | 1,368 | 1,363 | 1,236 | 599 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$2.10 |
2025-12-31 | -$0.97 |
2025-09-30 | $0.62 |
2025-06-30 | -$3.26 |